title: Dual VEGF/EGFR inhibition versus single targeted agent treatment in patients with metastatic colorectal cancer: a meta-analysis of randomized trials.
authors.affiliation: Department of Pharmacy, First Affiliated Hospital of Chinese PLA General Hospital, 51 Fucheng Road, Beijing, 100048, China. lxbj@hotmail.com.
authors.forename: Xiang
authors.initials: X
authors.lastname: Li
authors.affiliation: Medical Department, No. 263 Clinical Department, Beijing Military General Hospital, 141 Yongshun South Street, Beijing, 101149, China.
authors.forename: Min
authors.initials: M
authors.lastname: Wang
authors.affiliation: Department of Pharmacy, First Affiliated Hospital of Chinese PLA General Hospital, 51 Fucheng Road, Beijing, 100048, China.
authors.forename: Gui-Yang
authors.initials: GY
authors.lastname: Liu
authors.affiliation: Department of Pharmacy, First Affiliated Hospital of Chinese PLA General Hospital, 51 Fucheng Road, Beijing, 100048, China.
authors.forename: Jian-Li
authors.initials: JL
authors.lastname: Ma
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D058990:Molecular Targeted Therapy; D016032:Randomized Controlled Trials as Topic; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D028761:Withholding Treatment
chemical_list: D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; D066246:ErbB Receptors